SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010174
Filing Date
2019-11-06
Accepted
2019-11-06 16:24:50
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20190930x10q.htm 10-Q 2400426
2 EX-31.1 ardx-20190930ex311c008d4.htm EX-31.1 22352
3 EX-31.2 ardx-20190930ex3124696ed.htm EX-31.2 22336
4 EX-32.1 ardx-20190930ex321e1ec06.htm EX-32.1 16885
  Complete submission text file 0001558370-19-010174.txt   8062823

Data Files

Seq Description Document Type Size
5 EX-101.INS ardx-20190930.xml EX-101.INS 1824365
6 EX-101.SCH ardx-20190930.xsd EX-101.SCH 47078
7 EX-101.CAL ardx-20190930_cal.xml EX-101.CAL 59470
8 EX-101.DEF ardx-20190930_def.xml EX-101.DEF 183255
9 EX-101.LAB ardx-20190930_lab.xml EX-101.LAB 358931
10 EX-101.PRE ardx-20190930_pre.xml EX-101.PRE 325865
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 191196672
SIC: 2834 Pharmaceutical Preparations